Background The preoperative C-reactive protein/Albumin (CRP/Alb) ratio has been shown
to be valuable in predicting the prognosis of patients with certain cancers. The aim of our …

Despite significant progress regarding clinical detection/imaging evaluation modalities and
genetic/molecular characterization of pathogenesis, advanced renal cell carcinoma (RCC) …

Preclinical knowledge of dysregulated pathways and potential biomarkers for urological
cancers has undergone limited translation into the clinic. Moreover, the low approval rate of …

Background Carbonic anhydrase IX (CAIX) protein has been correlated with progression
and survival in patients with renal cell carcinoma (RCC). The prognostic value of CAIX in …

Background Many patients experience recurrence of renal cell carcinoma (RCC) after
radical and partial nephrectomy. Radiomics nomogram is a newly used noninvasive tool that …

Objectives: To immunohistochemically evaluate the carbonic anhydrase IX (CA IX)
expression on 1,551 cases of tumors and normal tissues from various organs. Methods …

Background: C-reactive protein (CRP), considered as a prototypical inflammatory cytokine,
has been proposed to be involved in tumor progression through inflammation. Recent …

Renal cell carcinoma (RCC) is one of the most commonly diagnosed cancers in the United
States. It accounts for approximately 4.0% of new cancers and 2.3% of cancer-specific …

Results MicroRNAs are essential regulators of various processes such as cell proliferation,
differentiation, development and death; they have been implicated in diverse biological and …

In this study, we performed bioinformatics and statistical analyses to investigate the
prognostic significance of metabolic genes in clear cell renal cell carcinoma (ccRCC) using …